Company: GNMSF
Filing Date: 2025-02-12
Form Type: 20-F
Source: 0001558370-25-000846
Chunk: 173

Company: GENMAB A/S
Filing Date: 2025-02-12
Form: 20-F
Item: Item 19
Chunk 173
---
ITEM 19   EXHIBITS 

a.   Annual Report
------------------
The following pages from our Annual Report 2024, furnished to the SEC as Exhibit 99.1(a) to Form 6-K, dated February 12, 2025 are incorporated by reference into this Form 20-F. The content of websites, scientific articles and other sources referenced on these pages are not incorporated by reference into this Annual Report on Form 20-F.
Page(s) incorporated by reference from our Annual Report 2024
Financial Review – pages 52-60
Consolidated Financial Statements for the Genmab Group – pages 139-182

119

Consolidated Statements of Comprehensive Income for the years ended December 31, 2024, 2023 and 2022 – page 140
Consolidated Balance Sheets as of December 31, 2024 and 2023 – page 141
Consolidated Statements of Cash Flows for the years ended December 31, 2024, 2023 and 2022 – page 142
Consolidated Statements of Changes in Equity for the years ended December 31, 2024, 2023 and 2022 – page 143
Notes to the Consolidated Financial Statements – pages 144-182

b.   Exhibits
-------------
Exhibit Index

 ​     ​                                                                             ​                                                                              ​                                                                         ​                                                                          ​
--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
1.1    ​   English translation of Articles of Association of Genmab A/S, as currently in effect                                                                     ​   Incorporated by reference to the Registrant’s Report furnished to the SEC on Form 6-K on January 29, 2025                                        ​
​      ​   ​                                                                                                                                                        ​   ​                                                                                                                                                ​
2.1    ​   Amended and Restated Deposit Agreement                                                                                                                   ​   Incorporated by reference to Exhibit (a)(3) to the Registrant’s Form F-6 filed with the SEC on July 15, 2019                                     ​
​      ​   ​                                                                                                                                                        ​   ​                                                                                                                                                ​
2.2    ​   Form of American Depositary Receipt                                                                                                                      ​   Included in Exhibit 2.1, which is incorporated by reference to Exhibit (a)(3) to the Registrant’s Form F-6 filed with the SEC on July 15, 2019   ​
​      ​   ​                                                                                                                                                        ​   ​                                                                                                                                                ​
2.3    ​